Mucocutaneous lesions of Behçet's disease

Yonsei Medical Journal

Volumn 48, Issue 4, 2007, Pages 573-585

  Alpsoy, Erkan ^a   Zouboulis, Constantin ^b   Ehrlich, George Edward ^c  

^a AKDENIZ UNIVERSITY   (Turkey)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Beh et's disease; Mucocutaneous lesions; Review; Treatment

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; AMINOSALICYLIC ACID; AMLEXANOX; ASCORBIC ACID; AZATHIOPRINE; BENZYDAMINE; BETAMETHASONE; CHAMOMILE; CHLORHEXIDINE; COLCHICINE; CYCLOSPORIN A; DAPSONE; DEXAMETHASONE; HEXETIDINE; HYDROGEN PEROXIDE; INDOMETACIN; LIDOCAINE; MEPIVACAINE; METHOTREXATE; PENTOXIFYLLINE; PLACEBO; PREDNISOLONE; SILVER NITRATE; SUCRALFATE; TETRACAINE; TETRACYCLINE; THALIDOMIDE; TRIAMCINOLONE; UNINDEXED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTHRALGIA; ARTHROPATHY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEHCET DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG INDUCED HEADACHE; DRUG INTERMITTENT THERAPY; EARLY DIAGNOSIS; ERYTHEMA NODOSUM; EYE DISEASE; FLU LIKE SYNDROME; GASTROINTESTINAL DISEASE; GENITAL ULCER; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; HUMAN; MOUTH ULCER; NAUSEA; OLIGOSPERMIA; PAPULE; PARESTHESIA; PERIPHERAL NEUROPATHY; PREVALENCE; PUSTULE; REVIEW; SIDE EFFECT; SKIN DEFECT; SKIN MANIFESTATION; SOMNOLENCE; THROMBOPHLEBITIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VASCULITIS; VOMITING; WEIGHT REDUCTION; XEROSTOMIA; FEMALE; MALE; PATHOLOGY; SKIN ULCER;

BEHCET SYNDROME; FEMALE; HUMANS; MALE; ORAL ULCER; SKIN ULCER; THROMBOPHLEBITIS;

EID: 34848835726     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2007.48.4.573     Document Type: Review

References (84)

1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999;341:1284-91.
2. Ehrlich GE, Kajani M, Schwartz IR, McAlack RF. Further studies of platelet rosettes around granulocytes in Behçet's syndrome. Inflammation 1975;1:223-5.
3. Lehner T. Immunopathogenesis of Behçet's disease. Ann Med Interne (Paris) 1999;150:483-7.
4. Alpsoy E, Yilmaz E, Coşkun M, Savaş A, Yeǧin O. HLA antigens and linkage disequilibrium patterns in Turkish Behçet's patients. J Dermatol 1998;25:158-62.
5. Alpsoy E, Çayirli C, Er H, Yilmaz E. The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet's disease: as a marker of disease activity. J Dermatol 1998;25:513-6.
6. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
7. O'Neill TW, Rigby AS, Silman AJ; Barnes C. Validation of the International Study Group criteria for Behçet's disease. Br J Rheumatol 1994;33:115-7.
8. Zouboulis CC. Epidemiology of Adamantiades-Behçet's disease. Ann Med Interne (Paris) 1999;150:488-98.
9. Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Adamantiades-Behçet's disease: Epidemiology in Germany and in Europe. In: Lee S, Bang D, Lee E-S, Sohn S, editors. Behçet's Disease. A Guide to its Clinical Understanding. Textbook and Atlas. Berlin, Heidelberg: Springer; 2001. p.157-69.
10. Müftüoǧlu AU, Yazici H, Yurdakul S, Pazarli H, Ozyazgan Y, Tüzün Y, et al. Behçet's disease: lack of correlation of clinical manifestations with HLA antigens. Tissue Antigens 1981;17:226-30.
11. Yamamoto S, Toyokawa H, Matsubara J, Yanai H, Inaba Y, Nakae K. A nation-wide survey of Behçet's disease in Japan. 1. Epidemiological survey. Jpn J Ophthalmol 1974;18:282-90.
12. Saylan T, Ozarmaǧan G, Azizlerli G, Ovül C, Oke N. Behçet's disease in Türkey. Z Hautkr 1986;61:1120-2.
13. Gürler A, Boyvat A, Türsen U. Clinical manifestations of Behçet's disease: an analysis of 2147 patients. Yonsei Med J 1997;38:423-7.
14. Zouboulis CC, Kötter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997;38:411-22.
15. Durusoy C, Alpsoy E, Elpek GO, Karpuzoǧlu G. Histological findings and androgen receptor levels in the sebaceous glands of papulopustular lesions from patients with Behçet's disease and acne vulgaris: A Controlled Study. Adv Clin Path 2002;6:87-93.
16. Yazici H, Tüzün Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdoǧan H, et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984; 3:783-9.
17. Demiroǧlu H, Barişta I, Dündar S. Risk factor assessment and prognosis of eye involvement in Behçet's disease in Turkey. Ophthalmology 1997;104:701-5.
18. Yazici H, Başaran G, Hamuryudan V, Hizli N, Yurdakul S, Mat C, et al. The ten-year mortality in Behçet's syndrome. Br J Rheumatol 1996;35:139-41.
19. Alpsoy E, Dönmez L, Bacanli A, Apaydin C, Butun B. Review of the chronology of clinical manifestations in 60 patients with Behçet's disease. Dermatology 2003; 207:354-6.
20. Alpsoy E, Aktekin M, Er H, Durusoy Ç, Yilmaz E. A randomized, controlled and blinded study of papulopustular lesions in Turkish Behçet's patients. Int J Dermatol 1998;37:839-43.
21. Alpsoy E, Er H, Durusoy Ç, Yilmaz E. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study. Arch Dermatol 9199;135:529-32.
22. Main DM, Chamberlain MA. Clinical differentiation of oral ulceration in Behçet's disease. Br J Rheumatol 1992, 31;767-70.
23. Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S. Epidemiological and clinical features of Behçet's disease in Korea. Yonsei Med J 1997;38:428-36.
24. Ghate JV, Jorizzo JL. Behçet's disease and complex aphthosis. J Am Acad Dermatol 1999;40:1-18.
25. Schreiner DT, Jorizzo JL. Behçet's disease and complex aphthosis. Dermatol Clin 1987;5:769-78.
26. Chajek T, Fainaru M. Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) 1975;54:179-96.
27. Alpsoy E, Durusoy Ç, Yilmaz E, Özgüret Y, Ermiş O, Yazar Ş, Başaran E. Interferon alpha-2a in the treatment of Behçet disease: a randomized, placebo-controlled and double-blind study. Arch Dermatol 2002;138:467-71.
28. Greenberg MS. HIV-associated lesions. Dermatol Clin 1996;14:319-26.
29. Jorizzo JL, Taylor RS, Schmalstieg FC, Solomon AR, Daniels JC, Rudloff HE, et al. Complex aphthosis: a forme fruste of Behçet's syndrome? J Am Acad Dermatol 1985;13:80-4.
30. Arbesfeld SJ, Kurban AK. Behçet's disease. New perspectives on an enigmatic syndrome. J Am Acad Dermatol 1988;19:767-79.
31. Stratigos AJ, Laskaris G, Stratigos JD. Behçet's disease. Semin Neurol 1992;12:346-57.
32. Ergun T, Gürbüz O, Doǧusoy G, Mat C, Yazici H. Histopathologic features of the spontaneous pustular lesions of Behçet's syndrome. Int J Dermatol 1998;37: 194-6.
33. Jorizzo JL, Abernethy JL, White WL, Mangelsdorf HC, Zouboulis CC, Sarica R, et al. Mucocutaneous criteria for the diagnosis of Behçet's disease an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol 1995;32:968-76.
34. Alpsoy E, Uzun S, Akman, A, Acar MA, Memişoǧlu HR, Başaran E. Histologic and immunofluorescence findings of non-follicular papulopustular lesions in patients with Behçet's disease. J Eur Acad Dermatol Venereol 2003;17:521-4.
35. Kim B, LeBoit PE. Histopathologic features of erythema nodosum-like lesions in Behçet disease: a comparison with erythema nodosum focusing on the role of vasculitis. Am J Dermatopathol 2000;22:379-90.
36. Chun SI, Su WP, Lee S, Rogers RS. Erythema nodosumlike lesions in Behçet's syndrome: a histopathologic study of 30 cases. J Cutan Pathol 1989;16:259-65.
37. Koç Y, Güllü I, Akpek G, Akpolat T, Kansu E, Kiraz S, et al. Vascular involvement in Behçet's disease. J Rheumatol 1992; 19:402-10.
38. Kansu E, Özer FL, Akalin E, Güler Y, Zileli T, Tanman E, et al. Bebçet's syndrome with obstruction of the venae cavae. A report of seven cases. Q J Med 1972;41: 151-68.
39. Demircioǧlu FF, Böke E, Demircin M, Daǧsali S, Küçükali T. Abdominal aortic aneurysm with inferior vena cava obstruction: case report. Angiology 1989;40: 227-32.
40. Azizlerli G, Ozarmaǧan G, Ovül C, Sarica R, Mustafa SO. A new kind of skin lesion in Belçet's disease: extragenital ulcerations. Acta Derm Venereol 1992;72:286.
41. Krülger, K, Fritz K, Daniel V, Zouboulis CC. Juvenile Adamantiades-Behçet disease in decreased stimulation with anti-CD3 monoclonal antibody. Hautarzt 1997;48: 258-61.
42. Treudler R, Orfanos CE, Zouboulis CC. Twerity-eight cases of juvenile-onset Adamantiades-Behçet disease in Germany. Dermatology 1999;199:15-9.
43. Altaç M, Tüzün Y, Yurdakul S, Binyildiz P, Yazici H. The validity of the pathergy test (non-specific skin hyperreactivity) in Behçet's disease: a double-blind study by independent observers. Acta Derm Venereol 1982;62:158-9.
44. Ergun T, Gürbüz O, Harvell J, Jorizzo J, White W. The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behçet's disease. Int J Dermatol 1998; 37:929-33.
45. Jorizzo JL, Solomon AR, Cavallo T. Behçet's syndrome. Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 1985;109:747-51.
46. Fresko I, Yazici H, Bayramiçli M, Yurdakul S, Mat C. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçet's syndrome. Ann Rheum Dis 1993;52:619-20.
47. Oǧuz O, Serdaroǧlu S, Tüzün Y, Erdoǧan N, Yazici H, Savaşkan H. Acute febrile neutrophilic dermatosis (Sweet's syndrome) associated with Behçet's disease. Int J Dermatol 1992;31:645-6.
48. Cho KH, Shin KS, Sohn SJ, Choi SJ, Lee YS. Belçet's disease with Sweet's syndrome-like presentation-a report of six cases. Clin Exp Dermatol 1989;14:20-4.
49. Armas JB, Davies J, Davis M, Lovell C, McHugh N. Atypical Behçet's disease with peripheral erosive arthropathy arid pyoderma gangrenosum. Clin Exp Rheumatol 1992;10:177-80.
50. Lee ES, Bang D, Lee S. Dermatologic manifestation of Behçet's disease. Yonsei Med J 1997;38:380-9.
51. Golan G, Beeri R, Mevorach D. Henoch-Schonlein purpura-like disease representing a flare of Behçet's disease. Br J Rheumatol 1994;33:1198-9.
52. Cornelis F, Sigal-Nahum M, Gaulier A, Bleichner G, Sigal S. Behçet's disease with severe cutaneous necrotizing vasculitis: response to plasma exchange-report of a case. J Am Acad Dermatol 1989; 21:576-9.
53. Cantini F, Salvarani C, Niccoli L, Senesi C, Truglia MC, Padula A, et al. Behçet's disease with unusual cutaneous lesions. J Rheumatol 1908;25:2469-72.
54. Liao YH, Hsiao GH, Hsiao CH. Behçet's disease with cutaneous changes resembling polyarteritis nodosa. Br J Dermatol 1999;140:368-9.
55. King R, Crowson AN, Murray E, Magro CM. Acral purpuric papulonodular lesions as a manifestation of Behçet's disease. Int J Dermatol 1995;34:190-2.
56. Kienbaum S, Zouboulis CC, Waibel M, Orfanos CE. Chemotactic neutrophilic vasculitis: a new histopathological pattern of vasculitis found in mucocutaneous lesions of patients with Adamantiades-Behçet's disease. In: Wechsler B, Godeau editors. Behçet's disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo; 1993. p.337-41.
57. Lakhanpal S, Tani K, Lie JT, Katob K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985;16:790-5.
58. Kienbaum. S, Zouboulis ChC, Waibel M, Orfanos CE. Papulopustular skin lesions in Adamantiades-Behçet's disease show a similar histopathological pattern as the classical mucocutaneous manifestations. In: Wechsler B, Godeau P, editors. Behçet's disease. International Congress Series 1037, Excerpta Medica, Amsterdam London New York Tokyo; 1993. p.331-6.
59. Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, et al. Adamantiades-Behçet's disease: Interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 2000;292:279-84.
60. Treudler R, Zouboulis CC, Büttner P, Detmar M, Orfanos CE. Enhanced interaction of patients' lymphocytes with human dermal microvascular endothehail cell cultures in active Adamantiades-Behçet disease. Arch Dermatol 1996;132:1323-9.
61. Zouboulis CC, Kurz K, Bratzke B, Orfanos CE. Adamantiades-Behçet disease: necrotizing systemic vasculitis With a fatal outcome Hautarzt 1991;42:451-4.
62. Gamble CN, Wiesner KB, Shapiro RF, Boyer WJ. The immune complex pathogenesis of gionferulonephritis and pulmonary vasculitis in Behçet's disease. Am J Med 1979;66:1031-9.
63. Jorizzo JL, Hudson kD, Schmatastieg FC, Daniels JC, Apisarnthanarax P, Henry JC, et.al. Behçet's syndrome: immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy. J Am Acad Dermatol 1984;10:205-14.
64. Hay D, Reade PC. The use of an elimination diet in the treatment of recurrent aphthous ulceration of the oral cavity. Oral Surg Oral Med Oral Pathol 1984;57:504-7.
65. Greer RO, Lindenmuth JE, Juarez T, Khandwala A. A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg 1993;51:243-9.
66. Matthews RW, Scully CM, Levers BG, Hislop WS. Clinical evaluation of benzydamine, chlorhexidine, and placebo mouthwashes in the management of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1987;63:189-91.
67. Graykowski EA, Kingman A. Double-blind trial of tetracycline in recurrent aphthous ulceration. J Oral Pathol 1978;7:376-82.
68. Collier PM, Neill SM, Copeman PW. Topical 5-aminosalicylic acid: a treatment for aphthous ulcers. Br J Dermatol 1992;126:185-8.
69. Hamuryudan V, Özyazgan Y, Hizli N, Mat C, Yurdakul S, Tüzün Y, et al. Azathioprine in Behçet's syndrome: effects on long-term prognosis. Arthritis Rheum 1997; 40:769-74.
70. Simsek H, Dundar S, Telatar H. Treatment of Behçet's disease with indomethacin. Int J Dermatol 1991;30:54-7.
71. Yasui K, Ohta K, Kobayashi M, Aizawa T, Komiyama, A. Successful treatment of Behçet's disease with pentoxifylline. Ann Intern Med 1996;124:891-3.
72. Chandrasekhar J, Liem AA, Cox NH, Paterson AW. Oxypentifylline in the management of recurrent aphthous oral ulcers: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:564-7.
73. Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y, Hamuryudan V, Uysal O, et al. A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum 2001;44:2686-92.
74. Sharquie KE. Suppression of Behçet's disease with dapsone. Br J Dermatol 1984;110:493-4.
75. Zouboulis CC, Orfanos CE. Treatment of Adamantiades-Behçet disease with systemic interferon alfa. Arch Dermatol 1998;134:1010-6.
76. Katsantonis J, Seltmann H, Wrobel A, Adler YD, Hornemann S, Orfanos CE, et al. Xenobiotic regulation of endothelial intracellular and secreted interleukin-8 induced by serum of patients with Adamantiades-Behçet's disease. In: Bang D, Lee E-S, Lee S, editors. Behçet's Disease. Proceedings of the 9th International Conference on Behçet's Disease and the 8th International Conference on Behçet's Disease. Seoul: Library of Congress Cataloging; 2001. p.236-9.
77. Yazici H, Pazarli H, Barnes CC, Tüzün Y, Ozyazgan Y, Silman A, et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990;322:281-5.
78. Avci O, Gürler N, Güneş AT. Efficacy of cyclosporine on mucocutaneous manifestations of Behçet's disease. J Am Acad Dermatol 1997;36:796-7.
79. Jorizzo JL, White WL, Wise CM, Zanolli MD, Sherertz EF. Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet's disease. J Am Acad Dermatol 1991;24:973-8.
80. Jorizzo JL, Schmalstieg FC, Solomon AR, Cavallo T, Taylor RS, Rudloff HB, et al. Thalidomide effects in Behçet's syndrome and pustular vasculitis. Arch Intern Med 1986;146:878-81.
81. Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, et al, Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998;128:443-50.
82. Goossens PH, Verburg RJ, Breedveld FC. Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy. Ann Rheum Dis 2001;60:637.
83. Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody. Gut 2001;49:725-8.
84. Robertson LP, Hickling P. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab. Rheumatology (Oxford) 2001;40:473-4.